↓ Skip to main content

Humanized Anti-hepatocyte Growth Factor Monoclonal Antibody (YYB-101) Inhibits Ovarian Cancer Progression

Overview of attention for article published in Frontiers in oncology, July 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (64th percentile)
  • Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

twitter
3 X users
patent
1 patent

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
8 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Humanized Anti-hepatocyte Growth Factor Monoclonal Antibody (YYB-101) Inhibits Ovarian Cancer Progression
Published in
Frontiers in oncology, July 2019
DOI 10.3389/fonc.2019.00571
Pubmed ID
Authors

Hyun Jung Kim, Sukmook Lee, Yong-Seok Oh, Ha Kyun Chang, Young Sang Kim, Sung Hee Hong, Jung Yong Kim, Young-Whan Park, Song-Jae Lee, Seong-Won Song, Jung Ju Kim, Kyun Heo

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 8 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 8 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 1 13%
Student > Bachelor 1 13%
Student > Master 1 13%
Unknown 5 63%
Readers by discipline Count As %
Unspecified 1 13%
Biochemistry, Genetics and Molecular Biology 1 13%
Medicine and Dentistry 1 13%
Unknown 5 63%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 June 2022.
All research outputs
#7,360,834
of 25,385,509 outputs
Outputs from Frontiers in oncology
#2,600
of 22,432 outputs
Outputs of similar age
#125,193
of 360,226 outputs
Outputs of similar age from Frontiers in oncology
#54
of 289 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 22,432 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 360,226 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.
We're also able to compare this research output to 289 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 79% of its contemporaries.